Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Investing Cash Flow

$3.96M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Investing Cash Flow

Latest reported$3.96Mperiod endingJun 30, 2026

Latest reported$3.96Mperiod endingJun 30, 2026

LCTX Quarterly Cash from Investing ($0.00 → $3.96M)

Quarterly investing cash flow

High-resolution chart · PNG

LCTX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Investing Cash Flow — Quarterly (USD)
Period ending	Investing Cash Flow (USD)
Jun 30, 2001	-3,639
Mar 31, 2001	-1,477
Dec 31, 2000	0
Sep 30, 2000	-4,588
Jun 30, 2000	-21,311
Mar 31, 2000	-7,503
Dec 31, 1999	-61,719
Sep 30, 1999	0
Jun 30, 1999	-100,000
Mar 31, 1999	0
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	0
Dec 31, 1997	-100,000
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Sep 30, 1995	0
Jun 30, 1995	3,000,000
Mar 31, 1995	0
Dec 31, 1994	1,900,000
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	-5,000,000
Dec 31, 1993	1,900,000
Sep 30, 1993	0
Jun 30, 1993	-2,000,000
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.